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Abstract
Background: Complex interventions encompassing several interconnecting and interacting components can be
challenging to evaluate. Examining the underlying trial processes while an intervention is being tested can assist in
explaining why an intervention was effective (or not). This paper describes a process evaluation of a pan-European
cluster randomised controlled trial, OptiBIRTH (undertaken in Ireland, Italy and Germany), that successfully used both
quantitative and qualitative methods to enhance understanding of the underlying trial mechanisms and their effect
on the trial outcome.
Methods: We carried out a mixed methods process evaluation. Quantitative and qualitative data were collected
from observation of the implementation of the intervention in practice to determine whether it was delivered
according to the original protocol. Data were examined to assess the delivery of the various components of the
intervention and the receipt of the intervention by key stakeholders (pregnant women, midwives, obstetricians).
Using ethnography, an exploration of perceived experiences from a range of recipients was conducted to
understand the perspective of both those delivering and those receiving the intervention.
Results: Engagement by stakeholders with the different components of the intervention varied from minimal
intensity of women’s engagement with antenatal classes, to moderate intensity of engagement with online
resources, to high intensity of clinicians’ exposure to the education sessions provided. The ethnography
determined that, although the overall culture in the intervention site did not change, smaller, more individual
cultural changes were observed. The fidelity of the delivery of the intervention scored average quality marks
of 80% and above on repeat assessments.
Conclusion: Nesting a process evaluation within the trial enabled the observation of the mode of action of
the intervention in its practice context and ensured that the intervention was delivered with a good level of
consistency. Implementation problems were identified as they arose and were addressed accordingly. When
dealing with a complex intervention, collecting and analysing both quantitative and qualitative data, as we
did, can greatly enhance the process evaluation.
Trial registration: Current Controlled Trials Register, ISRCTN10612254. Registered on 3 April 2013.
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Background
The interventions being tested in health services research
are becoming increasingly more complex, encompassing
several interconnecting and interacting components [1].
Although the primary outcome is the main focus of com-
plex research studies, consideration of the study processes,
including design and execution, is equally important.
Evaluation of the underlying processes of a complex
study assists in explaining why an intervention has
failed unexpectedly or has unforeseen consequences or
why a particular intervention is successful in achieving
its outcome, and how that success can be optimised [1].
Information about the process of a study is also very
helpful for study replication.
Process evaluations are particularly important in cluster
randomised trials, where the studies take place across sev-
eral sites with a variety of contexts in which the interven-
tion is both delivered and received. In these situations a
‘standardised’ intervention may, in reality, be implemented
in different ways or be the subject of different reactions
[2]. A resulting ‘lack of effect’ may thus merely indicate
problems with implementation rather than true ineffect-
iveness [3]. Variation in intervention delivery has implica-
tions for both internal and external validity and reduces
the potential for generalisability of findings.
A process evaluation used within a trial is a useful way
of assessing how well the trial protocol was adhered to
[3]. This can help explain how well all aspects of the
protocol were followed with regard to recruitment, treat-
ment fidelity, data collection and reporting. This struc-
tured process can help identify issues and factors that
may have caused a deviation in expected outcomes, and
it may illuminate local contextual factors which could
have impacted the trial implementation, which might
not otherwise have become apparent to the trial team.
The OptiBIRTH trial (ISRCTN10612254) research
team developed a process evaluation plan to explore and
document the implementation of the various aspects of
the complex OptiBIRTH intervention and how it was re-
ceived by key stakeholders, as well as to identify factors
that could explain variation in outcomes, if any, across
intervention sites. In this paper, we report on the Opti-
BIRTH process evaluation procedures, fidelity to the
intervention at the 15 trial sites and preliminary findings
from the embedded ethnographic study. The OptiBIRTH
trial results will be reported separately. The Template
for Intervention Description and Replication (TIDieR)
checklist was used to guide the structure and content of
this paper [4].
Context
The OptiBIRTH trial was a cluster randomised con-
trolled trial, with randomisation at the maternity unit
level, in three European countries with relatively low
vaginal birth after caesarean section (VBAC) rates. The
trial took place across 15 small (<2000 annual births),
medium (2000–5000 annual births) and large maternity
units (5000–8500 annual births) in both urban and rural
locations in Ireland, Italy and Germany, with baseline
VBAC rates in 2012 of 34% in Germany, 32% in Ireland
and 8% in Italy. In all three countries, publicly funded
maternity care is provided free of charge, but there is
also a private healthcare model existing in parallel.
There are some variations between countries in the way
services are delivered, but the units in the OptiBIRTH
trial provided a model of care that was obstetrics-led,
and all births occurred in hospital. In general, women
book at the maternity hospitals for antenatal care at
around 19–20 weeks of gestation in Ireland, 24–26
weeks in Italy and 28–32 weeks in Germany (although
these women attend primary care centres for their initial
maternity care). Multiparous women in all three coun-
tries would usually be in the range of 33–36 years of
age, and 10–20% would have three or more children.
National guidelines on VBAC existed prior to the Opti-
BIRTH trial in Ireland, and guidelines on VBAC were in-
cluded in a guideline on caesarean section (CS) in Italy
[5, 6]. A national VBAC guideline was withdrawn in
Germany because it was considered to be outdated. The
objective of the trial, as set out in the published proto-
col, was to compare the effectiveness of usual care ver-
sus an intervention that had been developed with the
intention of maximising VBAC [7]. A total of 2002
women were recruited to participate in the trial across
the 15 sites in the 3 countries (1195 in the intervention
arm and 807 in the control arm). Because the interven-
tion was complex with multiple interconnected compo-
nents that were delivered to a variety of stakeholders
(pregnant women, midwives, obstetricians) at different
times, we planned a parallel process evaluation to assess
adherence to agreed intervention delivery content and
methods and to enhance understanding of the under-
lying trial mechanisms. The objectives of the process
evaluation, designed on the basis of existing theoretical
and methodological literature, were as follows:
 To provide information on the intervention and how
it was planned to be delivered [8, 9]
 To provide information on the context in which the
intervention was implemented [8, 9]
 To measure the interaction between the intervention
and the context [8] (i.e., the response of clusters and
individuals to the intervention [10])
 To ascertain the fidelity of the intervention and how
closely it matched the intended intervention [10]
 To explore the mechanisms of adaptation and
change [11] occurring in one Irish site as the
intervention was introduced
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Information on the intervention
The OptiBIRTH intervention was developed on the basis of
evidence from three systematic reviews on interventions
designed to increase VBAC rates [12–14] and from findings
from focus group interviews with 115 clinicians [15, 16]
and 71 women [17, 18] in 6 countries, 3 with high (Finland,
the Netherlands, Sweden) and 3 with low (Ireland, Italy and
Germany) VBAC rates. Through an iterative process with
key stakeholders and using motivational theory to guide its
formation, the final complex intervention consisted of mul-
tiple interconnected components (Table 1).
Once the clinical leaders of a study site had agreed to
the site’s participation in the trial, all clinicians were in-
cluded as agents of intervention conduct. Clinical opin-
ion leaders (OLs) in midwifery (MOL) and obstetrics
(OOL) from the site staff were appointed by interview.
The MOLs’ role was to promote and support VBAC, to
act as research assistants for the study and to deliver the
intervention. The OOLs’ role was to promote and sup-
port VBAC, to deliver the intervention and to support
the MOLs. A 1-day training programme for OLs was de-
veloped by the core research team, consisting of the co-
ordinator, project manager, country principal investiga-
tors (PIs) and country post-doctoral researchers [19].
The training was delivered by the national OptiBIRTH
research team (PIs and post-doctoral researchers in each
country) to all OLs in the nine intervention sites (three
per country). A follow-up meeting, attended by all OLs,
the PI and the post-doctoral researcher in each country,
took place at the end of the pilot study or in the first
few weeks of the main study to encourage sharing of
successful techniques for recruitment and ideas for im-
provement in implementation. The OLs attended on-
line and face-to-face training sessions on how to access
and use the materials on the website. The OLs subse-
quently provided the access information to women and
clinicians as part of the intervention. They also each re-
ceived a comprehensive manual detailing a precise,
structured programme of how exactly the clinicians’ in-
formation sessions and women’s education sessions
were to be delivered.
Aspects of the OptiBIRTH intervention were designed
to be delivered to the maternity staff in the maternity
unit clusters. Cluster-level aspects of the intervention in-
cluded information for clinicians on VBAC and rising
CS rates, the benefits and risks related to VBAC and re-
peat CS, and ways to increase VBAC rates, all provided
in a 1-h information session. Delivery of the clinician’s
information sessions commenced as soon as the recruit-
ment of women began in the antenatal clinics and con-
tinued until the last OptiBIRTH baby was born. The
information and all relevant published papers referred to
in those sessions were available in a secure section of
the OptiBIRTH website, called ‘shecanbirth’, to which cli-
nicians were given a site-specific password. All clinicians
providing care to pregnant women were expected to at-
tend this session at least once during the study. The
intention was that cluster-level delivery of the interven-
tion would influence the underlying culture of the ma-
ternity unit where pregnant women received their care.
Further aspects of the OptiBIRTH intervention were
designed to be delivered to the individual pregnant
women attending the maternity units. These included
motivationally enhanced educational materials for
women, which were conveyed in two face-to-face educa-
tion sessions of 2 h each. Women were able to bring sig-
nificant others (partners, mothers, children) with them
to these sessions if they desired. The first session, facili-
tated at 24–31 weeks of gestation, addressed the previ-
ous CS birth and introduced the topic of VBAC. The
second session, facilitated at 31–35 weeks of gestation,
was focused on preparing for birth in the current preg-
nancy. Delivery of the antenatal classes for women com-
menced as soon as the first recruited woman reached
24 weeks of gestation and continued until the last Opti-
BIRTH baby was born. However, because these women
were not first-time mothers, we anticipated that they
would have challenges regarding attendance at antenatal
classes, so the PowerPoint presentations used for the
classes, with an accompanying voice-over, were also pro-
vided on the study website to enable a greater propor-
tion of women to engage with them. The online
component (consisting of the PowerPoint presentations
shown in the face-to-face antenatal classes and three
phone applications [‘apps’]), including a birth planner,
was available for women in a secure section on the Opti-
BIRTH website, called ‘icanbirth’, to which they were
given an individual password. The online resources were
available in English, German and Italian. Women could
seek individual support from the MOLs by telephone,
face-to-face meeting, or through the website (up to a
total of 2 h per week). The intention was that deliv-
ery of the intervention at the individual woman level
would influence the extent to which women felt in-
formed and engaged in decision-making about their
choice of mode of birth and thus could and would
achieve their planned VBAC.
Table 1 Interconnected components of the intervention
Intervention components
Appointment of local clinical opinion leaders in midwifery and obstetrics
Motivationally enhanced educational materials for women, which were
conveyed in two face-to-face education sessions
Information for clinicians on VBAC and repeat caesarean section
provided in a 1-h information session
An OptiBIRTH website subdivided into two sections: one for women
called ‘icanbirth’ and one for clinicians called ‘shecanbirth’
VBAC Vaginal birth after caesarean section
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Women in the intervention sites could participate at
two levels: consent to receive the full OptiBIRTH inter-
vention (i.e., plan to attend the antenatal classes) or con-
sent to provide only ‘routine data’ (i.e., chose not to
attend/engage with the classes and the online resources
but give the research team permission to access their
healthcare records). The aim of this process evaluation
was to monitor the implementation of the OptiBIRTH
intervention throughout the trial, collect data on aspects
of the process of intervention implementation and assess
fidelity to the intervention so that the relationship be-
tween trial outcomes and differences in the amount and
quality of the intervention at each site could be explored.
Methods
We used a combination of both qualitative and quantita-
tive methods to monitor the fidelity of the intervention,
the response of the clusters and the response of preg-
nant women to the intervention as well as the mecha-
nisms of adaptation and change at the intervention site
as described in the subsections below.
The fidelity of the intervention
Intervention fidelity refers to the degree to which the
prescribed components of the intervention, as described
in the study protocol, have been delivered [20]. The ex-
tent to which the OptiBIRTH intervention was delivered
as intended and the quality of that delivery were
assessed during formal fidelity checks designed by the
research team. A post-doctoral researcher observed the
OLs’ delivery of the education sessions to women and
the delivery of the 1-h information session to clinicians
to check adherence to the planned, structured delivery.
In each trial country, the same researcher visited all
three intervention sites on two occasions at least 6 weeks
apart, once in the pilot study phase and once in the early
main study phase, to observe and record fidelity to the
agreed delivery methods. We developed a structured ob-
servational checklist to measure fidelity while we ob-
served the OLs delivering the sessions. The checklist
criteria were based on the standardised training and the
OL manual we had designed. The checklist of pre-
determined criteria was administered consistently by a
member of the research team not involved in delivering
the intervention. The checklist for both the women’s
and the clinicians’ sessions consisted of items related to
the degree of adherence by the facilitator to the educa-
tion classes’ planned content and the quality of the de-
livery of the intervention components, rated either
dichotomously (yes, done as planned; or no, not as
planned) or using a Likert scale. Nonspecific factors
such as empathy, communication style, credibility, en-
gagement and sensitivity were rated using a Likert scale.
The tool comprised 111 items for monitoring the
women’s class and 86 items for the clinicians’ class, from
which we calculated the overall score for the quality
mark. We created an a priori specification of the ideal
and minimally acceptable quality mark for delivery of
the women’s classes and the clinician’s information
sessions (Table 2).
The response of pregnant women
This refers to the extent to which the individual re-
cruited women engaged with the various components of
the OptiBIRTH intervention. We created an a priori spe-
cification of the ideal and minimally acceptable treat-
ment dose (Table 3). The treatment dose refers to the
amount of the components of the intervention delivered
by implementers and the extent to which participants
received and used materials or other resources [19, 20].
This provides information about the degree to which the
intended audience engaged with the intervention. In our
case we measured treatment dose by documenting at-
tendance by the women at the antenatal classes.
We also monitored the online activity to assess levels of
engagement by the OptiBIRTH women with the online
components of the intervention. A survey was created
using the QUALTRICS web-based tool (www.qualtrics.
com) for completion by those using ‘icanbirth’, which was
the secure section on the OptiBIRTH website for women.
To monitor the amount of individual support women
sought, the MOLs logged the number of individual
telephone or face-to-face contacts from women re-
cruited into the study and documented the total time
spent advising women.
The response of the clusters
This refers to the extent to which the maternity units
and professionals therein adopted (or not) the interven-
tion into their existing systems and everyday work [10].
The results of the fidelity checks and documentary evi-
dence of attendance rates at the clinicians’ information
sessions informed this section. Again, we created an a
priori specification of the ideal and minimally acceptable
treatment dose (Table 4), which in this case was clini-
cians’ class attendance rates.
We also monitored online activity to assess levels of
engagement by the clinicians with the online compo-
nents of the intervention. A survey was created on
Table 2 Rating scale for the quality of delivery of the classes
and information sessions
High quality Both antenatal classes delivered with an average
quality mark of at least 80%
Moderate quality Both antenatal classes delivered with an average
quality mark of 65–79%
Low quality Both antenatal classes delivered with an average
quality mark of 50–64%
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QUALTRICS for completion by those using ‘shecanbirth’,
which was the secure section on the OptiBIRTH website
for clinicians.
The mechanisms of adaptation and change in the
intervention site
An ethnographic study was conducted at one of the
intervention sites in Ireland to explore the mechanisms
of adaptation and change following the introduction of
the intervention [21]. A 16-month period of observation
took place throughout the study. Twelve clinicians and
15 women were interviewed before, during and after the
introduction of the intervention. The MOL at the site
was interviewed three times and the OOL once through-
out the study period.
Results
The fidelity of the intervention
Fidelity checking during delivery of the intervention
yielded average quality marks of 80% and above at all
sites. During fidelity checking and other random site
visits by the post-doctoral researcher, OLs were observed
to be delivering the intervention consistently and to a
level of high quality.
The response of pregnant women to the intervention
There were 1073 women recruited to receive the full
OptiBIRTH intervention. A further 122 women chose
the ‘routine data only’ participation, which gave us per-
mission to access the healthcare records for the woman
and her baby, but those women chose not to engage
with the classes and the online resources [7]. The docu-
mentary evidence of attendance rates at the women’s
education sessions showed that in Ireland, 42% (162
women) of OptiBIRTH women attended class 1 and 37%
(143 women) attended class 2; in Germany, 19% (91
women) attended class 1 and 17% (81 women) attended
class 2; and in Italy, 54% (166 women) attended class 1
and 38% (117 women) attended class 2. These rates were
low and correspond to an a priori level of ‘no interven-
tion’. Women rated the usefulness of these classes on a
10-point Likert scale, with 0 being of no use at all and
10 being the most useful, in a 3-month postnatal survey.
Ninety percent of the 341 women who attended both
classes rated the classes in the top 5 points of the scale,
with 40% scoring the classes as 9 or 10 on the scale.
An evaluation of the online environment and the apps
was an integral component of the overall project. The
frequency of log-ins, including repeat and unique
visitors, to the OptiBIRTH website was documented.
There were 2608 visits by women recorded on the
OptiBIRTH website. Among the women engaging with
the OptiBIRTH intervention, for the trial as a whole,
97% (n = 1037) of the 1073 women recruited to receive
the intervention registered to use the online resources.
Of those who registered, 55% (n = 570) logged in to the
website a total of 2608 times. Three online apps were
designed to be completed sequentially: app 1 had to be
completed before app 2, and app 2 had to be completed
before app 3 (Fig. 1). Our analysis shows that 30% of
registered women (n = 173) completed app 1, 46% (n = 79)
of these women completed app 2 and 57% (n = 45) com-
pleted app 3. The overall app use for women recruited to
receive the intervention (n = 1073) was 16% for app 1, 7%
for app 2 and 4% for app 3 Additonal file 1.
Logs of the individual support provided by the MOLs
to women revealed that although many women did not
request any more support than that provided by the
classes and the online components, a small number of
women required intense personal support. In addition,
the MOLs logged a significant amount of time spent on
individual contacts around consent reminders and class
attendance arrangements. Over the duration of the
study, the individual contact provided by the MOLs to
women averaged more than the 2 h per week that had
been anticipated.
The response of the clusters
Attendance lists at the clinicians’ sessions were main-
tained, duplicates were removed (many clinicians
attended more than once) and proportions were calcu-
lated using whole time equivalent numbers provided by
human resources departments. In Ireland 80% of
Table 3 Rating scale for the intensity of the intervention (women)
High intensity >60% of recruited women attending two antenatal classes or >80% of recruited women attending one antenatal class
Moderate intensity >50% of recruited women attending two antenatal classes or >65% of recruited women attending one antenatal class
Low intensity >40% of recruited women attending two antenatal classes or >50% of recruited women attending one antenatal class
“No intervention” 0–40% of recruited women attending two antenatal classes or 0–50% of recruited women attending one antenatal class
Table 4 Rating scale for the intensity of the intervention
(clinicians)
High intensity >70% of clinicians attending the
information session
Moderate intensity >60% of clinicians attending the
information session
Low intensity >50% of clinicians attending the
information session
“No intervention” 0–50% of clinicians the information session
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midwives and 80% of doctors attended. In Germany at-
tendance rates were 80% of midwives and 95% of doc-
tors, whereas in Italy 52% of midwives and 57% of
doctors attended. This corresponds to a high intensity
achieved for the clinicians’ interventions in Ireland
and Germany. Italy achieved a lower level of intensity.
The frequency of log-ins, including repeat and unique
visitors, to the OptiBIRTH website was documented.
There were 443 visits by clinicians recorded on the
OptiBIRTH website.
The mechanisms of adaptation and change in one Irish
site
The observational, field notes and interview data col-
lected during the ethnographic study conducted at one
of the intervention sites in Ireland showed that the inter-
vention underwent a process of ‘ritualisation’ to become
embedded and accepted as ‘routine’ in daily practice.
Women also developed study-specific identities; that is,
they became ‘OptiBIRTH women’ by virtue of participat-
ing in the study. Transference of authoritative know-
ledge, in particular, during the educational classes was
also observed as a central tenet of intervention delivery.
Lastly, the effect of various power positions (women-cli-
nicians, women-women, midwives-obstetricians) also af-
fected intervention delivery, including how it was
viewed, accepted and implemented at the field site. The
ethnography demonstrated that although the overall cul-
ture in this intervention site did not change, smaller,
more individual cultural changes were observed, in par-
ticular observations of women emerging as the main
drivers of change around VBAC as the intervention
phase of the study progressed [22].
Discussion
The design and execution of research studies become
more challenging as the interventions being evaluated
move from simple towards more complex interventions
with several components [3]. This is further com-
pounded when such studies take place across several
sites in several countries with multiple distinct work
packages within the study design, as was the case with
the OptiBIRTH trial. The OptiBIRTH trial took place in
15 maternity units across 3 different countries. Birth
rates in the three countries differed, with 1.95 per
woman in Ireland, 1.37 in Italy and 1.47 in Germany
[23]. Understanding of the outcomes of such complex
trials, conducted in a variety of practice settings, could
be greatly improved by better understanding of the pro-
cesses of the trials. Smyth et al. suggested that accounts
of the reality of undertaking research, with all its chal-
lenges, are missing from the currently available literature
[24]. Process evaluations nested within trials may ad-
dress this deficit. It is widely recognised that such
process evaluations move beyond exploring whether an
intervention works but also explore how the interven-
tion works, why it works (or not), when it works, who is
needed to make it work, what is needed to make it work,
and if it can work again in other contexts, including bar-
riers to its being adopted and having effect.
Conducting a process evaluation parallel to the Opti-
BIRTH trial enabled us to ensure that the intervention
was delivered appropriately. Fidelity monitoring identified
Fig. 1 Online apps designed for the OptiBIRTH intervention
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implementation problems as they arose and allowed us to
address them accordingly. Observations by a post-
doctoral researcher as a non-participant of the OLs deliv-
ering the education and information sessions removed the
potential for social desirability bias that may have oc-
curred with self-reported assessment by the OLs. The ini-
tial observations at the beginning of the trial revealed
minor issues around confidence with delivery and com-
mand of the subject matter. An action plan was imple-
mented in which the post-doctoral researcher explained
to the OLs the evidence informing the intervention and
role-played the delivery of that evidence in the sessions.
The MOLs were very comfortable and confident engaging
with the OptiBIRTH women, but less so about presenting
to their peers, especially their obstetrics colleagues whom
they felt would ask them questions they were unable to
answer. The availability of the post-doctoral researcher
and the obstetric OL to accompany the MOLs in a coach-
ing capacity at the beginning of the trial when they were
delivering the sessions was instrumental in building their
confidence and their technique. During the clinicians’ ses-
sions, difficulty with delivery at an appropriate pace was
identified and was due to an excess of material to be deliv-
ered within the hour-long clinicians’ session. This was ad-
dressed by re-organising and/or removing some of the
content. The difficulties resolved as the OLs became more
confident and more familiar with the literature informing
the sessions. Average quality marks of 80% and above
were achieved on repeat assessments in all sites. Although
there is a lack of clear guidelines about what the optimal
level of adherence should be, most agree that 80–100%
constitutes high fidelity, whereas 50% constitutes low fi-
delity [19]. In addition to acting as a support for the OLs,
regular site visits by the post-doctoral researcher enabled
quality assurance throughout the trial. For the OptiBIRTH
study, a post-doctoral researcher acted in this capacity,
but for other studies this role could be fulfilled by a pro-
ject manager or a research supervisor.
Balancing fidelity in terms of ‘adherence to intervention’
versus application to context and flexibility to respond to
individuals’ needs was challenging. Context-level adapta-
tion does not necessarily mean that the integrity of what is
being delivered and evaluated across multiple sites is lost,
but uncontrolled variations in the implementation of the
intervention may threaten the study’s integrity [25, 26].
The context within which intervention studies take place
may sometimes challenge the way in which interventions
are delivered [27], and the variety of practice settings was
a particular complexity in this trial. We needed to pre-
serve the core components of the intervention but facili-
tate the flexibility required by the practice settings. The
research team decided that it was preferable to have a
structured programme requiring strict adherence to a set
format because the trial covered three countries, with
three intervention sites in each, and had to be designed to
be suitable for transfer to all European countries. We stan-
dardised the training for the OLs delivering the interven-
tion to ensure that the intervention was delivered
systematically and consistently. A structured training
manual offered the advantages of greater consistency and
precision in the delivery of the intervention and enhanced
internal validity [28]. Thus the OptiBIRTH training man-
ual and the observation tool for assessing fidelity were
very structured around the core components of the inter-
vention. However, flexibility was accommodated around
secondary aspects such as the timing and location of the
women’s classes. The clinicians’ session was designed in
such a way that it could be delivered as a single 1-h ses-
sion or split into four 15-minute sessions as the need
arose. This enabled the delivery of the intervention to be
maximised while being responsive to local contexts and
allowed us to deliver and evaluate a very structured inter-
vention in a ‘real-world’ practice context. We believe that
the highly structured manual used in the context of very
experienced OLs delivering the intervention allowed us to
achieve the correct balance between standardisation for
internal validity and flexibility for external validity.
We were able to observe the mode of action of the
intervention in its practice context by monitoring the re-
sponse of the maternity unit cluster and the pregnant
women to the intervention. Our process evaluation re-
vealed that there was a variable level of engagement by
stakeholders with the different components of the inter-
vention. This varied from minimal intensity of women’s
engagement with antenatal classes, to moderate intensity
of engagement with online resources, to high intensity of
clinicians’ exposure to the education sessions provided.
Preferential recruitment was not the method used for
this trial; however, women could choose whether they
took part in two ways, either as full participants or as
‘routine data only’ participants, and those who agreed to
join and to attend classes may have been more interested
in achieving a VBAC. This will have had no effect on the
trial outcome, because the primary outcome was the
VBAC rate after trial completion compared with the
VBAC rate in the year prior to the trial for all women at
the study sites.
The low intensity of women’s engagement with ante-
natal classes, though disappointing, was not altogether
surprising. Engaging women who are not first-time
mothers with antenatal education is notoriously difficult.
A national survey of women’s experience of maternity
care conducted in the United Kingdom in 2010 found
that only 12% of multiparous women compared with
67% of first-time mothers attended antenatal education
[29]. The OptiBIRTH women already had children, so
child-minding while they attended classes may have
been a challenge. The classes were delivered between 24
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and 35 weeks of gestation and so occurred before mater-
nity leave had begun. The OLs were very pragmatic and
adaptable in trying to mitigate those challenges, and they
tried to deliver the classes at a variety of times, including
morning, midday, evenings and even weekends, to ac-
commodate the women. They ensured that the infra-
structure in which they delivered the sessions was safe
and suitable for any woman wanting to bring children
with her. Classes were provided for any number of
women who were able to attend, regardless of whether it
was as low as 2 women or as many as 15 women. How-
ever, despite all their efforts, attendance at the classes
was less than we would have liked. The women who did
manage to attend the classes rated them very highly in
their follow-up 3-month postnatal survey.
Perhaps some of the solution to poor attendance at
antenatal education classes lies in the online resources.
There were 3051 visits by users (2608 by women, 443 by
clinicians) recorded on the OptiBIRTH website, suggest-
ing that there is potential for the website to be improved
and developed further to provide a more interactive en-
vironment where women could attend a virtual class.
However, further research is required to establish
women’s preferences. The OptiBIRTH women attending
the classes seemed to really appreciate the opportunity
to not only engage freely with an obstetrician and mid-
wife but also with other women who had experienced a
previous CS and were now negotiating a birth after a
previous CS. The ethnographic findings around the
women forming a new identity as ‘OptiBIRTH women’
suggests a collective identity emerging from meeting
other women at the classes, something that may not
happen in an online forum.
A high intensity of clinicians’ exposure to the education
sessions provided was achieved in Ireland and Germany.
The information sessions for all clinicians at each site
were delivered by the OLs on a rolling basis so that each
clinician would attend the session at some time during the
trial. Again, the OLs were very pragmatic and adaptable in
trying to mitigate challenges around attendance at these
sessions. The information to be delivered required 1 h in
total but was formatted in such a way that it could be de-
livered in four distinct 15-minute sessions if required. An
example of the practical application of this flexibility oc-
curred where one MOL delivered the 15-minute sessions
on 4 successive nights to her midwifery colleagues who
were on a week of night duty. The 15-minute sessions also
worked well in areas such as the antenatal clinics where
staff worked stable hours as opposed to shifts. Rather than
ask busy clinicians to find another hour in their already
packed schedules, the OLs tried to deliver the sessions
wherever possible within already existing meetings such
as weekly risk management meetings, perinatal case study
meetings, midwifery case review meetings or further
education classes. The OptiBIRTH clinicians’ session be-
came part of the mandatory induction week for newly
appointed junior doctors in many of the sites. From re-
cruitment of the first OptiBIRTH participant to the birth
of the last OptiBIRTH baby, the study lasted 21 months
and so spanned a number of rotations of junior doctors
and new midwifery staff. Being able to meet those doctors
and midwives at induction ensured that they were aware
of the study and that they also received evidence-based in-
formation about VBAC as soon as they began working at
the study site. The senior obstetricians and midwives were
instrumental in ensuring that their teams of junior clini-
cians attended the sessions but also role-modelled the be-
haviour by attending the sessions themselves. Having
senior level buy-in is vital for all change processes. To en-
courage attendance at the sessions, the MOLs at each site
collected data on study eligibility rates, recruitment rates,
VBAC, and elective and emergency repeat CS rates, and
they presented these data to clinicians quarterly at the end
of the session. The clinicians’ exposure to the education
sessions ensured that clinicians gained evidence-based
knowledge on VBAC which helped VBAC become a legit-
imate option for women with a previous CS and helped
clinicians and women jointly make an informed decision
about trying for a VBAC.
The lower level of engagement by clinicians in Italy is
most likely due to a culture that is less receptive to the
concept of VBAC. There are a number of reasons for
this, among them being the highly medicalised models
of care for pregnancy and childbirth delivered largely by
obstetricians in a private setting with midwives having a
minimal role, limited skills among those clinicians
around VBAC, and a widespread culture of fear and risk
that leads to a specialists bias in dealing with CS and
VBAC. The pre-trial VBAC rates in Italy were extremely
low at only 8%.
Although it was not possible to measure the nature of
the change in the attitudes or behaviours of the health-
care staff providing care to the pregnant women directly,
it is possible to measure changes in the rates of VBAC
in the sites. Descriptions of the contexts in which inter-
ventions are implemented may help improve under-
standing of the intervention’s effectiveness, the findings
of the study and their generalisability [3, 25]. In addition
to the contextual complexity of multiple countries and
multiple sites, the OptiBIRTH intervention was delivered
at sites that had low but variable background VBAC
rates at the beginning of the trial. The baseline rate of
VBAC for women with one previous CS for a 12-month
calendar year preceding the start of the study was re-
corded at each site prior to introduction of the interven-
tion. That information gave an indication of the attitude
towards VBAC from both women and clinicians at that
site. Such attitudes at both individual and cluster levels
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may influence response to the intervention. VBAC base-
line rates for the year after the completion of the study
(2016) have been collated and are currently being ana-
lysed. This will provide an indication of the degree of
change in the care that clinicians delivered to the
women they encountered and will also provide some in-
formation about sustainability (or not) of the effect. The
embedded ethnographic study seems to be suggesting
that the mechanism of adaptation and change, al-
though slower than expected, was beginning to effect
change towards the end of the trial period [21]. The
embedded ethnographic study was conducted at one
intervention site but has potential transferability to
other intervention sites.
The combination of both quantitative and qualitative
methods, including checklists, researcher observations,
and interviews, to monitor intervention implementation
at the OL (deliverer), individual woman (recipient) and
maternity unit staff (cluster) levels will make a valuable
contribution to explaining the outcomes of the study
and enhancing the credibility of the evidence. It also
provides a data trail of what happened during the imple-
mentation of the intervention. Embedding an ethno-
graphic study at one site enabled us to explore
midwives’, obstetricians’ and women’s experiences of the
intervention and their responses to it. This has signifi-
cant implications for dissemination of the study findings
but also for replication of the study in the future.
Limitations
Craig et al. acknowledged that there is no single best way to
conduct a process evaluation and suggested that process
evaluations need to be tailored to the trial, the intervention
and the outcomes being studied [3]. For pragmatic and
resource reasons, we had to decide where to focus our at-
tention for the purpose of the process evaluation for Opti-
BIRTH. There were certain aspects of the process on which
we were able to gather data (e.g., numbers attending both
the women’s and clinicians’ classes), but other aspects for
which we were less able to gather data (e.g., behavioural
change in practitioners), which would have required a
discrete substudy. When implementing a complex inter-
vention, using a combination of quantitative and qualitative
data as we did can greatly enhance the process evaluation.
The processes involved in the trial and intervention imple-
mentation, described above, were funded as part of the trial
and supported by a research team. Such support necessarily
ceases once funding ceases, and often initiatives founder at
that stage. Further important questions are thus how, and
why, these processes are sustained over time [8]. In the
OptiBIRTH trial, hospitals agreeing to join the study also
committed to continuing the intervention after trial end if
the intervention was found to be beneficial. A further study
will be required to determine if the intervention is more ef-
fective over time and if that effect is sustained.
Conclusion
This paper describes the pragmatic conduct of a process
evaluation that ran parallel with the conduct of the Opti-
BIRTH trial. Implementing theoretical interventions in
real-world practice settings is complicated and can be
imprecise. Adequate testing of complex interventions
can be enhanced by parallel process evaluations that
monitor and assess the mode of action of an interven-
tion as it is applied in a practice setting. To be able to
make accurate interpretations of outcomes, research
teams need to know what intervention components were
delivered and to what quality and consistency. It is
widely accepted that better implementation leads to bet-
ter outcomes and that multiple factors affect implemen-
tation [26]. Therefore, process evaluation is absolutely
essential for interpreting findings about the effects of in-
terventions tested in trials, particularly if those interven-
tions are complex. We can conclude from our process
evaluation that the OptiBIRTH intervention was deliv-
ered during the trial as per the trial protocol.
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